Characteristics of changes of intrahepatic lymphocyte subsets in mouse with hepatic fibrosis induced by carbon tetrachlorideand dimethylnitrosamine and the regulatory effect of Fuzheng Huayu Formula
Experiment Research|更新时间:2022-08-29
|
Characteristics of changes of intrahepatic lymphocyte subsets in mouse with hepatic fibrosis induced by carbon tetrachlorideand dimethylnitrosamine and the regulatory effect of Fuzheng Huayu Formula
Academic Journal of Shanghai University of Traditional Chinese MedicineVol. 36, Issue S1, Pages: 161-166(2022)
PING Dabing,SUN Xin,QI Jingshu,et al.Characteristics of changes of intrahepatic lymphocyte subsets in mouse with hepatic fibrosis induced by carbon tetrachlorideand dimethylnitrosamine and the regulatory effect of Fuzheng Huayu Formula[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(S1):161-166.
PING Dabing,SUN Xin,QI Jingshu,et al.Characteristics of changes of intrahepatic lymphocyte subsets in mouse with hepatic fibrosis induced by carbon tetrachlorideand dimethylnitrosamine and the regulatory effect of Fuzheng Huayu Formula[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(S1):161-166. DOI: 10.16306/j.1008-861x.2022.S1.037.
Characteristics of changes of intrahepatic lymphocyte subsets in mouse with hepatic fibrosis induced by carbon tetrachlorideand dimethylnitrosamine and the regulatory effect of Fuzheng Huayu Formula
YASUDA M,OKABE T,ITOH J,et al. Differentiation of necrotic cell death with or without lysosomal activation: application of acute liver injury models induced by carbon tetrachloride (CCL4) and dimethylnitrosamine (DMN)[J]. J Histochem Cytochem, 2000, 48(10): 1331-1339.
FAGGIOLI F,PALAGANO E,DI TOMMASO L,et al. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury[J]. Hepatology, 2018, 67(5): 1970-1985.
PENG Y, YANG T, HUANG K,et al. Salvia Miltiorrhiza ameliorates liver fibrosis by activating hepatic natural killer cells in Vivo and in Vitro[J]. Front Pharmacol,2018, 9: 762.
JIN Z X, SUN R,WEI H M, et al. Accelerated liver fibrosis in hepatitis B virus transgenic mice:involvement of natural killer T cells[J]. Hepatology, 2011, 53(1):219-29.
TEDESCO D, THAPA M, Sanjeev G, et al. CD4+ Foxp3+ T cells promote aberrant immunoglobulin G production and maintain CD8+ T-cell suppression during chronic liver disease[J]. Hepatology, 2017, 65(2): 661-677.
GUI H L, ZHAO C Q, WANG Y,et al. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis[J]. J Clin Transl Hepatol, 2020, 8(3): 277-284.
LIU C H,HU Y Y,XU L M,et al. Effect of Fuzheng Huayu formula and its actions against liver fibrosis[J]. Chin Med, 2009, 4: 12.
WU R, DONG S, CAI F F, et al. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis[J]. Molecules, 2019, 24(2): 338.
PAN Q, WANG Y Q, LI G M, et al. Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells[J]. Biomed Res Int,2015, 2015: 935903.
HU X Q,SONG Y N,WU R,et al. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats[J]. J Ethnopharmacol, 2019, 238: 111888.